Our mission is to provide accurate and useful health information. If we determine that our content contains confusing, misleading or inaccurate information, we will revise the content. This policy applies to all original content.
- In the condition guide Atypical teratoid rhabdoid tumor (ATRT), information about the drug tazemetostat was removed. This drug was pulled from the market due to safety concerns.
March 11, 2026
